[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-357295-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-357295-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","knowledge-mapping-and-research-trends-of-chimeric-antigen-receptor-t-cell-immunotherapy-in-breast-cancer-a-bibliometric-and-visual-analytics-study","Knowledge mapping and research trends of chimeric antigen receptor T-cell immunotherapy in breast cancer - A bibliometric and visual analytics study","","Chimeric antigen receptor T cell (CAR-T) immunotherapy has shown landmark success in hematologic malignancies and is increasingly explored for breast cancer and other solid tumors. This study retrieved 894 Web of Science records on CAR-T immunotherapy in breast cancer and used CiteSpace and VOSviewer to map research landscapes, development trajectories, and key contributors. Joinpoint regression quantified temporal publication trends. The USA led output; University of London and Technische Universität Dresden acted as central hubs. Core journals included CANCER RES and FRONT IMMUNOL, while Darcy PK and Morgan RA were prominent authors by output and citations. Keyword clustering showed sustained activity around in vivo, TME, and targeted therapy, with recent frontiers involving TME, epithelial-mesenchymal transition, and mesothelin.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/knowledge-mapping-and-research-trends-of-chimeric-antigen-receptor-t-cell-immunotherapy-in-breast-cancer-a-bibliometric-and-visual-analytics-study/357295/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/knowledge-mapping-and-research-trends-of-chimeric-antigen-receptor-t-cell-immunotherapy-in-breast-cancer-a-bibliometric-and-visual-analytics-study/357295.png","ImageObject",300,407,{"name":42,"@type":43},"Franzy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How many Web of Science records were analyzed for CAR-T immunotherapy in breast cancer?","Question",{"text":63,"@type":64},"The study retrieved 894 related records from the Web of Science Core Collection for bibliometric analysis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which tools were used for knowledge mapping and visualization?",{"text":68,"@type":64},"CiteSpace and VOSviewer were used to map the research landscape, development trajectory, and key contributors.",{"name":70,"@type":61,"acceptedAnswer":71},"What were identified as recent research frontiers in keyword burst detection?",{"text":72,"@type":64},"Burst detection highlighted emerging attention to TME, epithelial-mesenchymal transition, and mesothelin as research frontiers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},357295,1790504833,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","HUMAN VACCINES & IMMUNOTHERAPEUTICS 2026, VOL. 22, NO. 1, 2690841 [https://doi.org/10.1080/21645515.2026.2690841](https://doi.org/10.1080/21645515.2026.2690841)  \nRESEARCH ARTICLE     \nKnowledge mapping and research trends of chimeric antigen receptor T-cell immunotherapy in breast cancer: A bibliometric and visual analytics study  \nYuechen Xua, Yu Xub, Zhisen Wanga, Qiyi Yia, Fan Wangc, and Po Biana  \naInstitute of Radiation Medicine, School of Basic Medical Sciences, Anhui Medical University, Hefei, China; bTeaching and Research Section of Nuclear Medicine, School of Basic Medical Sciences, Anhui Medical University, Hefei, China; cDepartment of Oncology Radiotherapy, The First Affiliated Hospital of Anhui Medical University, Hefei, China  \nABSTRACT  \nChimeric antigen receptor T cell (CAR-T) immunotherapy has achieved landmark success in hematologic malignancies and is being explored for breast cancer (BC) and other solid tumors, prompting research to improve efficacy and safety. We retrieved 894 related to CAR-T immunotherapy for BC from the Web of Science Core Collection and performed bibliometric analyses using CiteSpace and VOSviewer to map the research landscape, development trajectory, and key contributors. Joinpoint regression assessed temporal trends in annual publications using R 4.4.2. The USA led publication output. Institutional co-occurrence revealed the University of London and Technische Universität Dresden as central hubs. CANCER RES and FRONT IMMUNOL were identified as core journals. Darcy PK and Morgan RA were prominent authors by output and citations. Keyword clustering and timeline visualization indicated that the terms “in vivo,”“tumor microenvironment (TME),” and “targeted therapy” have remained highly active in recent years. In addition, burst detection analysis revealed that keywords including TME,“epithelial-mesenchymal transition,” and “mesothelin” have gradually emerged as research frontiers, suggesting increasing attention to resistance mechanisms and tumor immune regulation. These findings provide a systematic overview of the evolving research landscape and help identify emerging hotspots and future directions. BC remains the most frequently diagnosed malignancy among women worldwide and a major cause of cancer-related death. We systematically mapped the knowledge structure and development trends of CAR-T research in BC, identifying major research contributors and emerging research hotspots, which may provide valuable insights for future basic research and clinical exploration in this field.  \nARTICLE HISTORY  \nReceived 19 March 2026 Revised 28 May 2026 Accepted 15 June 2026  \nKEYWORDS  \nChimeric antigen receptor T cells; breast cancer; bibliometric study;  \nCiteSpace; VOSviewer;  \nJoinpoint regression analysis  \nIntroduction  \nBreast cancer (BC) is the most frequently diagnosed malignancy among women worldwide and remains a major public health challenge because of its substantial incidence and mortality. 1 Despite continuous advances in therapeutic strategies, clinical outcomes remain unsatisfactory for specific subtypes, including metastatic disease, triple-negative BC (TNBC), and HER2-positive BC. These limitations highlight an urgent need for more effective and precisely targeted treatment approaches.  \nChimeric antigen receptor T-cell (CAR-T) therapy represents a transformative advancement in cellular immunotherapy. By leveraging genetic engineering, this approach modifies T lymphocytes to specifically recognize and eradicate tumor cells.2 The therapeutic efficacy of this modality hinges on the precise targeting of tumor antigens, which orchestrates a potent anti-tumor immune response.3,4 As a disruptive immunotherapeutic approach, CAR-T therapy has achieved remarkable and durable clinical success in hematological malignancies, prompting its translational exploration in solid tumors. In recent years, CAR-Thas been increasingly investigated in BC, with early-phase clinical and preclinical stud","cbCaiv7RKZtwAeFL","https://ap.wps.com/l/cbCaiv7RKZtwAeFL","pdf",10089859,17,"English","# Introduction\n## Background: breast cancer burden\n## CAR-T therapy and its translational exploration\n# Methods\n## Data source and bibliometric mapping\n## Temporal trend analysis\n# Results\n## Publication output and geographic leadership\n## Institutions and journal contributions\n## Author and keyword cluster findings\n# Discussion\n## Emerging research frontiers and future directions","[{\"question\":\"How many Web of Science records were analyzed for CAR-T immunotherapy in breast cancer?\",\"answer\":\"The study retrieved 894 related records from the Web of Science Core Collection for bibliometric analysis.\"},{\"question\":\"Which tools were used for knowledge mapping and visualization?\",\"answer\":\"CiteSpace and VOSviewer were used to map the research landscape, development trajectory, and key contributors.\"},{\"question\":\"What were identified as recent research frontiers in keyword burst detection?\",\"answer\":\"Burst detection highlighted emerging attention to TME, epithelial-mesenchymal transition, and mesothelin as research frontiers.\"}]","Knowledge mapping and research trends of chimeric antigen receptor T-cell immunotherapy in breast cancer - A bibliometric and visual analytics study | PDF",1790129556,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fd9e24f1ba94bf475e1a4fbb48f533a.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2265b2d5face6dcb0397a5c40c26eb0d.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/798d0d4a9b4f5cd6255c0ff3a65bd872.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/94f3b9a65be21b1ef9c7b037cc352b67.webp",980,1306]